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Abstract
Background: The aim of this study was to examine the frequency of articular cartilage calcification
in patients with end-stage hip OA. Further, its impact on the clinical situation and the OA severity
are analyzed.
Methods: Eighty patients with OA of the hip who consecutively underwent total hip replacement
were prospectively evaluated, and 10 controls were included. The patients' X-rays were analyzed
for the presence of articular cartilage mineralization. A Harris Hip Score (HHS) was preoperatively
calculated for every patient.
Slab specimens from the femoral head of bone and cartilage and an additional square centimeter of
articular cartilage from the main chondral defect were obtained from each patient for analysis of
mineralization by digital contact radiography (DCR). Histological grading was also performed. In a
subset of 20 patients, minerals were characterized with an electron microscope (FE-SEM).
Results: Calcifications were seen in all OA cartilage and slab specimens using DCR, while
preoperative X-rays revealed calcification in only 17.5%. None of the control cartilage specimens
showed mineralization. There was a highly significant inverse correlation between articular cartilage
calcification and preoperative HHS. Histological OA grade correlated positively with the amount
of matrix calcification. FE-SEM analysis revealed basic calcium phosphate (BCP) as the predominant
mineral; CPPD crystals were found in only two patients.
Conclusions: Articular cartilage calcification is a common event in osteoarthritis of the hip. The
amount of calcification correlates with clinical symptoms and histological OA grade.
Background
OA is frequently associated with calcium crystal deposi-
tion. Two forms of calcium crystals have been studied in
articular cartilage, meniscus tissue, and synovial fluid
from patients with OA: calcium pyrophosphate dihydrate
(CPPD) and basic calcium phosphate (BCP), including
partly carbonate-substituted hydroxyapatite, tricalcium
phosphate, and octacalcium phosphate [1-7].
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BMC Musculoskeletal Disorders 2009, 10:166 http://www.biomedcentral.com/1471-2474/10/166Despite many reports showing the pathologic incidence
of crystal deposition in osteoarthritic joints, there is much
controversy about the frequency and significance of this
association. In addition, most of the reports describe the
frequency of calcinosis in the knee; only a few reports are
about calcinosis of hip OA. Those findings indicate that
calcinosis and OA are related, but the conclusion is less
secure with the hip than with the knee [4,8].
A recent study by Mitsuyama et al. on 106 knees from 56
individual donors concluded that age rather than OA is
the predominant factor driving progressive pathologic cal-
cification in articular cartilage [9].
A clear understanding of the relationship between cal-
cium crystal deposition and osteoarthritis is limited by the
lack of a widely available and simple technique for detect-
ing these crystals; scanning radiographs for chondrocalci-
nosis, the radiographic hallmark of calcium crystal
deposition, is known to be insensitive [5]. Light and
Polarizing light microscopy is the method of choice for
detecting CPPD crystals, though only 20% of CPPD crys-
tals are birefringent and some are too small to be detected
by light or polarized light microscopy [1]. BCP crystals
with a diameter of 0.1 nm to 1.0 nm are too small to be
identified by light microscopy [2]. Diagnosis of minerali-
zation with histological techniques is not specific and is
often insensitive, especially in detecting single BCP crys-
tals or small agglomerates of these minerals [2]. Alizarin
red staining allows detection of calcium crystals and can
be of interest in detecting BCP crystals when CPPD are not
seen.
The clinical and pathological relevance of cartilage miner-
alization in patients with OA is not completely under-
stood. In a recent study of 120 patients with OA of the
knee, we could demonstrate that mineralization of articu-
lar cartilage by BCP is an indissociable process of OA and
not only characterizes a specific subset of OA, but corre-
lates significantly with clinical symptoms and the histo-
logical grade of the disease [10].
This study was performed on patients with end-stage OA
undergoing total hip replacement, to test the hypothesis
that calcification of the articular cartilage is a general phe-
nomenon in patients with hip OA, that cartilage calcifica-
tion has an impact on the clinical situation, and that
calcification is associated with aggravated joint degenera-
tion.
Methods
This study was approved by the Ethics Committee of the
Ärztekammer Schleswig-Holstein, Bad Segeberg, Ger-
many. All patients included in this study gave full written
informed consent for participation prior to the operative
procedure.
Eighty patients undergoing total hip arthroplasty between
October 2007 and February 2008 were included in this
prospective study. All patients had primary osteoarthritis
according to the ACR criteria for OA [11]. The indications
for surgery were pain and limited function. The mean age
of the patients was 69.9 years at the time of operation (±
0.86 SE, range 51-87); 53 were female and 27 were male
(Table 1).
As a negative control, 10 patients with malignant bone
tumors in the proximal femur (five osteosarcomas: 14, 15,
15, 16, and 18 years; two chondrosarcomas: 14 and 19
years; one metastasis of prostate cancer: 56 years; and two
specimens from metastasis of lung cancer: 58 and 63
years) were included. During total or proximal femur
replacement, cartilage was harvested from the unaffected
hip joint following the same procedure used for the
patients with OA.
Preoperatively, the OA patients were evaluated clinically
and radiographically. The clinical and functional results
were assessed with the Harris Hip Score (HSS) [12].
The patients' X-rays (standard AP and axial views) of the
hip joint were analyzed for the presence of articular chon-
drocalcinosis. The X-rays of the affected hip were viewed
by two orthopedic surgeons on the AP and axial views,
Table 1: Clinical data
OA patients
Number of patients 80
Female/male 53/27
Mean age at time of operation 69.9 (± 0.86 years, range 51-87)
Left/right knee 36/44
Mean body mass index 28.6 (± 2.9, range 17.2-29.5)
Mean duration of the disease 3.2y (± 1.2 years, range 0.9-10.2)
Mean preoperative Harris Hip score 51.73 points (± 1.42, range 16-79)
Preoperative X-ray OA grade (Kellgren) II: 4; III: 29; IV: 47
Clinical data on 80 patients with primary osteoarthritis of the hip are included in this study.Page 2 of 8
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not. Periarticular mineralization was excluded.
Preoperative OA grades were evaluated according to the
classification system of Kellgren and Lawrence [13].
During surgery, the entire resected femoral head was
obtained from every patient. Two different techniques
were used to obtain the cartilage specimens. First, the fem-
oral head was cut into three 5 mm thick slab specimens of
bone and cartilage in the coronal plane with the greatest
possible diameter. These slab specimens included the
mean weight-bearing area, the main chondral defect, and
the surrounding cartilage of the defect. Additionally,
about one square centimeter of articular cartilage from the
main chondral defect was obtained. Only the upper half
of the cartilage was cut off, to exclude subchondral bone
artifacts. These two types of specimens were taken from
every femoral head to extend the analyzed cartilage area
and to minimize artifacts.
Contact radiography (DCR)
First, each edge of the cartilage was trimmed and cleaned
with a clean blade, removing bone debris from the sawing
procedure to avoid contamination with bone dust from
surgery or processing. The two types of cartilage specimens
were used for detection and quantification of mineraliza-
tion in every patient. All specimens were fixed in 10% neu-
tral formalin prior to imaging. Three slab specimens and a
tangential cut of cartilage from every patient were radio-
graphed using a high-resolution digital mammography
device (Hologic) operating at 25 KV in manual mode, usu-
ally at 3.8 mAs, and a film focus distance of 8 cm [10]. Min-
eralization could be viewed as regions within the cartilage
matrix that appeared much brighter than the surrounding
cartilage tissue. These digital images were analyzed by
image-analysis software (ImageJ 1.32) [9,10]. This tech-
nique marks a given range of grey levels on the contact radi-
ographs to identify areas for measurement. By adjusting the
upper and lower bounds with a threshold utility, areas of
calcification could be highlighted and used to calculate the
percentage of mineralization in relation to the surrounding
whole cartilage area. In some cases, there was a gradient in
the cartilage due to varying thickness of the specimen. In
these cases, the mineralized area was identified using a
manual method, such as with a digital spray can tool.
Whichever way the mineralized area was marked, the per-
centage of mineralization was determined by dividing the
area of calcification by the whole area of cartilage. This gave
a relative concentration of calcification for each specimen.
The mean mineralization in the three slab specimens from
each patient was calculated and used for further analysis.
Histologic assessment
Histologic assessment was performed on the tangential
cut cartilage specimen after the DCR procedure. The spec-
imen was fixed in formalin, dehydrated by graded alco-
hols, and embedded in paraffin. Five-micrometer sections
were cut, stained and evaluated using a modified Mankin
grading system. The scores (on a scale of 0-14 points) for
mild (1), moderate (2), and severe (3) OA changes in
articular cartilage were 2-5, 6-9, and 10-14 points, respec-
tively [14,15].
Electron microscopy
Electron microscopy studies were performed on the tan-
gential-cut specimens from a subset consisting of the first
20 patients without further selection. They were fixed in
4% formalin, dehydrated in ascending alcohol sequence,
and transferred from 100% isopropanol to amylacetate
followed by critical-point drying (CPD). Mineral cartilage
characterization was achieved by means of a JEOL 6300F
field emission electron microscope (FE-SEM) equipped
with an energy-dispersive X-ray (EDX) system (Oxford
Inca), operating in secondary electron (SE) and back-scat-
tered electron (BSE) mode at various acceleration voltages
from 0.5-20 KeV. With the EDX system, X-ray spectra from
the material were collected and analyzed. The calcium
phosphate ratio was determined by this method and dis-
tinguished CPPD (Ca/P-ratio: 1) from BCP crystals (for
example, apatite, with a Ca/P-ratio of 1.67) [10].
Statistical analysis
The correlation between two continuous parameters was
analyzed by Spearman's correlation coefficient by rank
test. Correlation between independent samples was deter-
mined by the Kruskal-Wallis test. The results were
expressed as mean ± 2 standard error of mean (SE). A p
value less than 0.05 was considered to be significant.
Results
DCR but not conventional X-ray reveals mineralization of 
the articular cartilage in all OA patients, with correlation 
to the clinical data
Systematic analysis of the preoperative X-rays of the hips
revealed chondrocalcinosis in only 14 out of 80 patients
(17.5%). However, when DCR was performed on both
the tangential cut cartilage and the slab specimens, miner-
alization was found in all of them. The mean area of min-
eralization was 1.25% (± 0.14 SE, range 0.1-4.6%) for the
tangential cut cartilage and 3.69% (± 0.31 SE, range 0.3-
112.1) for the slab specimens.
As a part of the preoperative evaluation, clinical data were
obtained from all 80 patients and an HHS score was cal-
culated for each patient. The mean preoperative HHS was
51.73 points (± 1.42 SE, range 16-79). There was a signif-
icant inverse correlation between the preoperative HHS
score and the mean area of cartilage mineralization for
both the tangential cut articular cartilage and the slab
specimens (p < 0.05). Scatter plots show a significant
inverse relationship between HHS score and mean area ofPage 3 of 8
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words, patients with a large amount of articular cartilage
calcification showed worse preoperative clinical results
compared with patients who presented with only a small
amount of minerals in their articular cartilage.
Interestingly, there was no correlation between patient age
and mean area of cartilage mineralization observed in this
population (Figures 1C and 1D) (p = 0.342, p = 0.070).
There was also no significant correlation between patient
gender and mean area of cartilage mineralization, neither
for the tangential cut articular cartilage nor for the slab
specimens (tangential cut cartilage: female 1.30% ± 0.17
SE, male 1.16% ± 0.23 SE, p = 0.556; slab specimens:
female 3.72% ± 0.38 SE, male 3.65% ± 0.56 SE, p =
0.909).
Cartilage mineralization correlated with the degree of 
histologic changes
The patients were divided into three groups according to
the Mankin classification (mild I, moderate II, severe III),
as described in Methods. This population demonstrated a
statistically significant positive correlation between
Mankin OA grade and articular cartilage mineralization
for both the slab specimens and the tangential cut articu-
lar cartilage. This is illustrated in Figure 2A, where four
Cartilage mineralization and clinical relationshipsFigure 1
Cartilage mineralization and clinical relationships. Contact radiography (DCR) of tangential cut cartilage and slab spec-
imens revealed mineralization in all articular cartilage specimens. The mean area of mineralization was 1.25% (± 0.14 SE, range 
0.1-4.6%) for the tangential cut cartilage and 3.69% (± 0.31 SE, range 0.3-12.1) for the slab specimens. Scatter plots show a 
highly significant inverse correlation between HHS score and mean cartilage calcification for both the tangential cut articular 
cartilage and the slab specimens (A and B) (p < 0.01, p = 0.01). There was no correlation between patient age and the mean 
area of cartilage mineralization (C and D) (p = 0.342, p = 0.070).Page 4 of 8
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with their corresponding DCRs. Quantitative analysis of
all 80 samples showed a significant increase in cartilage
mineralization between cartilage specimens graded as
Mankin II and III. The comparison between Mankin I and
II did not show a significant increase in cartilage mineral-
ization (Figures 2B and 2C). The ten controls did not
present any mineralization, neither in the slab specimens
nor in the tangential cut articular cartilage. They also did
not present any mineralizations or any signs of OA on the
X-rays. In this context, no correlation was found between
patient age and radiological OA grade according to the
Kellgren classification (Kellgren II: 70.8 years at mean ±
2.5 SE; Kellgren III: 70.9 years at mean ± 1.7 SE; Kellgren
IV: 69.2 years at mean ± 1.7 SE). In addition, no correla-
tion was found between patient age and HHS or between
patient age and histological OA grade according to the
Mankin classification.
In a subset of 30 patients, there was high interobserver
and intraobserver correlation with regard to the mineral-
Cartilage mineralization and correlation with the degree of histologic changesFigure 2
Cartilage mineralization and correlation with the degree of histologic changes. Histological assessment was per-
formed on tangential cut cartilage using a modified Mankin scoring system. Three representative histological sections from each 
Mankin grade and one from the control group are shown with their corresponding DCRs. Whereas the 10 controls show 
intact articular cartilage with no mineralization detected, an increase in matrix mineralization with further cartilage destruction 
was observed by DCR (A). A statistically significant positive correlation between OA grade and articular cartilage mineraliza-
tion for both the slab specimens and the tangential cut articular cartilage was observed in specimens graded as Mankin II and III 
(I-II: p = 0.036; II-III: p = 0.001) (B, C).Page 5 of 8
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(kappa>0.95, p < 0.01).
Ultrastructural analysis demonstrates primary deposition 
of BCPs
After cartilage specimens were analyzed by DCR, electron
microscope analysis was performed on a subset of the first
20 consecutive tangential-cut cartilage specimens out of
the total 80. The mineralization in all patients identified
by DCR was proven to be calcium phosphate aggregates
with this technique. FE-SEM studies suggest the presence
of at least two phases, one nearly amorphous and one idi-
omorphic mineral phase, with different chemical compo-
sitions. Ten different spots on every specimen were
selected for chemical measurement of the crystals. The
two mineral phases contained calcium-phosphate ratios
similar to apatite (1.61 ± 0.073, range 1.48-1.71) or CPPD
(1.03 ± 0.068, range 0.96-1.24) crystals. Apatite-like min-
eral phases were detected in all patients, while CPPD crys-
tals were present in only two patients (Figure 3). Viewing
the FE-SEM pictures there were more BCP than CPPD crys-
tals in these two patients, but an exact quantification was
not possible.
These two patients with additional CPPD crystals had also
primary OA of their hips with no further metabolic disor-
ders possibly relevant for mineral deposition. Especially,
there was no evidence of hypercalcemia, hyperparathyre-
odism, hemochromatosis or disturbances of the vitamin
D or phosphate metabolism. Also no family history of
crystal arthropathies was present.
Discussion
In this prospective study, mineralization of articular carti-
lage was found in all patients undergoing total hip
replacement; no calcification was present in the young
control patients without a history of or histological evi-
dence for OA. In addition, we found a inverse correlation
between articular cartilage mineralization and clinical
symptoms. Also, a strong positive correlation between car-
tilage mineralization and histological OA grade has been
established. This is analogous to recent findings concern-
ing articular cartilage mineralization of OA knees, where
clinical and histological influence on articular cartilage
mineralization was also demonstrated [10].
There was no correlation between the ages of the patients
an amount of mineralization, though there was a trend
toward significance for the age and the DCR of the tangen-
tial cartilage. But there is a clear result with the slab speci-
men of a correlation between age and mean area of
mineralization definitely being excluded. The DCR of the
slab specimens are more accurate because the total
amount of measured cartilage is higher than in the tan-
gential cut cartilage.
Two recent studies have concluded that age rather than
OA is the predominant factor driving progressive patho-
logic mineralization in articular cartilage [9] and that
mineralization does not necessarily worsen OA progres-
sion [16]. Those results contrast in part with our findings.
Both authors concluded that cartilage mineralization may
be a precursor to increased OA rather than a result of this
degenerative condition.
The results of our study suggest that mineralization plays
in important role in OA because it is strongly associated
with histological and clinical OA severity. These results are
in direct contrast to the findings from Mitsuyama and col-
leagues [9]. They reported that mineralization was seen to
increase with age and between normal and mildly fibril-
lated cartilage only. No differences were observed in the
mineralization level if OA progressed beyond that mild
grade. No simple explanation for this paradox is apparent.
Patient selection, methods for detecting cartilage mineral-
ization, and a long list of possible artifacts, for example
the use of cartilage provided by tissue banks or obtained
after autopsy with the risk of postmortal artifacts, may
play a role.
From this study we cannot conclude if the calcification
was present before OA began or vice versa. But two facts
may indicate that mineralization is a result of OA and is
not merely age related: The controls without OA did not
show any mineralization, either in the contact or in the
FE-SEM analysis. Further, there was no correlation
between patient age and the amount of matrix mineraliza-
tion in this population. Though this population was care-
fully selected, a relationship between age and
mineralization would have been expected if aging was the
reason for cartilage mineralization.
As a further limitation of the study, the control group was
not optimal. The primary intention of having the control
group was to exclude measurements of artifacts. In 10
patients with no evidence of OA we could demonstrate
that the methods used to detect mineralization were able
to discriminate clearly between mineralized and nonmin-
eralized cartilage. The control group was not intended to
be an age-matched group. The correlation between age
and mineralization found in this population was not con-
trolled by the non-OA group.
An important observation is that the amount of cartilage
mineralization correlates with clinical symptoms, giving
reason to develop a therapeutic strategy that reduces min-
eralization in the cartilage to relieve symptoms of OA. As
a limitation of this study, the OA material studied was not
a random sample in that it was obtained from patients
who presented symptoms.Page 6 of 8
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tissue damage and inflammatory joint pain is stimulation
of cytokine production in synovial fibroblasts (SF): BCP
are observed to be an amplifier of PGE2 production
through induction of the COX enzymes and the proin-
flammatory cytokine IL-1β in SF and thereby contribute to
the severity of the synovial response [17]. But the
chondrocytes themselves may also play an active role in
cartilage destruction induced by microcrystals: Up-regula-
tion of matrix metalloproteinase production by chondro-
cytes [18] and direct activation of chondrocytes to induce
IL-1β and iNOS gene expression and NO production by
BCP (OCP) crystals was observed [19].
The technique used to identify mineralization combines
three different approaches and so minimizes artifacts. The
challenge in obtaining a tangential-cut cartilage specimen
is not touching the subchondral bone or the deep calcified
cartilage area. Osteophytes can also produce artifacts. But
bone artifacts can be distinguished from cartilage calcifi-
cation because of the structure shown by DCR. The slab-
cut specimens have a risk of showing false mineralization
produced by bone dust. In the FE-SEM analysis, these arti-
facts can be easily excluded by the fact that cartilage min-
eralization is surrounded by cartilage matrix or strongly
connected to the collagen fibers. Subchondral bone or
mineralization from the deep cartilage zone can easily be
distinguished from cartilage mineralization. In the FE-
SEM analysis, more mineralizations and crystals are visi-
ble than are detected by the DCR technique. Electron
microscopy of the first 20 specimens without further
selection revealed that BCP, like apatite, is the prominent
mineral, while CPPD crystals occur infrequently; only two
patients presented CPPD crystals.
Contact radiography using DCR on cartilage specimens
from a well-defined joint area is a sensitive technique for
detecting mineralizations, but not for analyzing them. It
gives an accurate assessment of the amount of mineraliza-
Electron microscope analysis of cartilage mineralizationFigu e 3
Electron microscope analysis of cartilage mineralization. FE-SEM analysis in combination with EDX was performed on 
a subset of 20 consecutive specimens out of the total 80. All areas of mineralization identified by DCR were proven to be cal-
cium phosphate aggregates using this technique. The FE-SEM studies detected one nearly amorphous (A, C) and one idiomor-
phic mineral (B, D) phase with different chemical compositions. The two mineral phases contained calcium-phosphate ratios 
similar to BCP (A, C) and CPPD crystals (B, D). BCP crystals were found in all patients, CPPD crystals additionally in two 
patients. Panel A show a cartilage specimen with apatite calcification at 15× magnification; panel C the same specimen at 500× 
magnification. Panel B (15×) shows a patient with CPPD crystals. In panel D (500× magnification), the typical rhomboid CPPD 
crystals (arrow) are visible.Page 7 of 8
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[10,20,21].
Conclusions
The fact that articular cartilage mineralization was found
in all specimens from patients with OA of the hip has a
significant impact on diagnostic strategies, treatment con-
cepts, and our understanding of OA. Mineralization of
articular cartilage is generally present in OA of the hips,
not only as a subentity in certain progressive forms of OA.
Agents that reduce crystal growth, such as phosphocitrate
[22] or first-generation bisphosphonates, [23] should be
considered as new therapeutic strategies to inhibit further
BCP crystal formation and to reduce clinical symptoms in
OA.
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